Cecilia Costa

Cecilia Costa

Auto-generated profile, based on publicly available information

Cecilia Costa

Infectious Diseases Unit, "Maggiore della Carità" University Hospital, Novara, Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Travel Medicine and Infectious Disease
Verified
Journal Article
Closed access
CCCecilia Costa
Cecilia Costa
AFAnna Ferrari
Anna Ferrari
RBRaffaella Binazzi
Raffaella Binazzi
ABAnna Beltrame
Anna Beltrame
DTDanilo Tacconi
Danilo Tacconi
FGFederico Gobbi
Federico Gobbi

1 March 2021 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
ATAlice Trentalange
Alice Trentalange
EBEnrica Borgogno
Enrica Borgogno
IMIlaria Motta
Ilaria Motta
MAMiriam Antonucci
Miriam Antonucci
VPVeronica Pirriatore
Veronica Pirriatore
ACAndrea Calcagno
Andrea Calcagno

29 June 2020 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
CCCecilia Costa
Cecilia Costa
SSSilvia Scabini
Silvia Scabini
AKArvind Kaimal
Arvind Kaimal
WKWilliam Kasozi
William Kasozi
Jessica CusatoJessica Cusato
Jessica Cusato
BCBarbara Castelnuovo
Barbara Castelnuovo
Data on bone health and renal impairment in people with human immunodeficiency virus (HIV) in resource-limited settings are limited. The primary aim of this study was to investigate the potential role of calcaneal quantitative ultrasonography (QUS) in predicting bone mineral density (BMD) reduction in a population of Ugandan HIV-infected individuals receiving long-term antiretroviral therapy; the secondary end point was to assess the prevalence of proximal tubular dysfunction and the correlation between elevated urinary retinol-binding protein–urinary creatinine ratio (uRBP/uCr) and reduced BMD. We conducted a cross-sectional study at the Infectious Diseases Institute, Kampala, Uganda. We included 101 HIV-infected adults who had been receiving continuous antiretroviral therapy for ≥10 years and had undergone dual-energy x-ray absorptiometry (DXA) during the previous 12 months. All patients underwent calcaneal QUS evaluation and urine sample collection. DXA BMD measurements were significantly associated (P < .01) with calcaneal speed of sound, broadband ultrasound attenuation, and QUS index. Forty-seven individuals (47%) had abnormal uRBP/uCr values. A significant inverse correlation was observed between uRBP/uCr and DXA T scores (lumbar [P = .03], femoral neck [P < .001], and total hip [P = .002]). Calcaneal QUS results showed a moderate correlation with DXA outputs. The identified high prevalence of subclinical tubular impairment also highlights the importance of expanding access to tenofovir disoproxil fumarate–sparing regimens in resource-limited settings.